CA and CAC was
94.7% and 94.8% at 6 months and 94.1% and 89.0% at
1 year, respectively. In a network meta-analysis, Kolluri
et al193 compared the early outcomes with VenaSeal
(Medtronic) with those after EVLA, RFA, MOCA, sclerotherapy, and open surgery. At 6 months, Vena